Clinical Trial News

Clinical Trial Information


Targeting cancer drugs to gene abnormalities


From the National Cancer Institute (NCI)  –  a NCI-MATCH Clinical Trial to link targeted cancer drugs to gene abnormalities.  This is a molecular analysis for therapy choice.  The Trial will seek to determine whether targeted therapies for patients whose tumors have specific gene mutations will be effective regardless of their cancer types.


NCI-Match will incorporate more than 20 different study drugs or drug combinations, each targeting a specific gene mutations in order to match each patient in the trial with a therapy that targets a molecular abnormality in her or his tumor.


Enrollment in the NCI-MATCH will be available across the country through NCTN sites and will also be available through sites nationwide that participate in the NCI Community Oncology Research Program – 2,400 sites can participate in the Trial.


This is a hopeful research focus for the future.

For more detailed information, go to:


The NCI offers a LIVE HELP ONLINE CHAT Monday-Friday 8 am – 11 pm EST:

1 -800-422-6237.



Reaching For the Cure Together

The Sarcoma Coalition is a nonprofit collaboration of 21 sarcoma advocacy organizations from around the country working toward a common purpose: To provide resources and support for those dealing with sarcoma – from patients and their families to allies in the research and medical communities.  Click Here to learn more.
Contribute to LMS Research 
"Invest" in Research - Support / Contribute to LMS Research Projects for 2018 -Click Here for more info